ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $691 | -86.8% | 34,798 | -88.6% | 0.01% | -86.0% |
Q1 2023 | $5,243 | -99.1% | 306,062 | +718.3% | 0.04% | +437.5% |
Q3 2022 | $597,000 | +145.7% | 37,402 | +111.6% | 0.01% | +166.7% |
Q2 2022 | $243,000 | -25.2% | 17,675 | -13.8% | 0.00% | -25.0% |
Q1 2022 | $325,000 | -83.6% | 20,494 | -43.2% | 0.00% | -78.9% |
Q4 2020 | $1,979,000 | +192.8% | 36,085 | +22.0% | 0.02% | +46.2% |
Q3 2020 | $676,000 | -4.4% | 29,569 | -4.8% | 0.01% | 0.0% |
Q4 2019 | $707,000 | +381.0% | 31,054 | +146.5% | 0.01% | +160.0% |
Q3 2019 | $147,000 | – | 12,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |